HPV Testing: A Global Strategic Business Report
San Jose, California (PRWEB) November 06, 2013
Follow us on LinkedIn – Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital HPV (human papilloma virus) infection.
Of all the types of HPV, around 13 are considered as high-risk viruses that could progress into cancer among those infected. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective in women who regularly participate in screening programs. While cytology based testing has been the most widely used screening technique, HPV testing is steadily gaining prominence. Development of advanced tests with better detection capabilities is fostering growth in the HPV testing market.
HPV testing is expected to gain acceptance in screening initiatives for women particularly in developed countries, due to the high level of false-negative cytology tests, and lack of proper follow up after positive test results in the current screening methods. Also, while the incidence rate of squamous cell carcinoma has been on the decline, cervical adenocarcinoma incidence has remained largely unchanged. This is a concern as it is extremely difficult to detect adenocarcinoma and its precursor lesions through cervical cytology tests. Given HPV testing’s greater sensitivity to high-grade cervical lesions in comparison to cytology tests, several countries are looking towards HPV testing as a primary cervical cancer screening test. Improving awareness about cervical cancer and government measures to prevent the disease are thus expected to aid the market’s progress in the coming years.
As stated by the new market research report on HPV Testing, the United States represents the largest market worldwide. HPV DNA testing in the country has achieved more than 75% penetration in the ASCUS (abnormal squamous cells of undetermined significance) population, although there is still enormous potential in the co-testing market as the penetration is around 45-50%. Growth in the domestic market will therefore be influenced by lengthening testing intervals and the fact that only 50% of the market is presently penetrated. Changes to cervical screening guidelines are also expected to influence adoption of HPV testing. In 2012, ASCCP, ACS and ACOG endorsed co-testing while the USPSTF upgraded co-testing to Grade A, a move indicative of potential expansion in HPV testing volumes in the country. Developing countries are also forecast to witness strong growth led by the fact that over 80% of new cases are reported annually in developing markets with high mortality rates. Majority of the deaths due to cervical cancer in these regions are attributed to low awareness levels, poor diagnostic infrastructure and little or no access to preventive tests. Significant untapped potential amidst rampant unmet medical needs therefore ranks as a key growth driver in developing countries.
Major players covered in the report include Abbott Molecular Inc., Arbor Vita Corporation, CytoCore® Inc., DaAn Gene Co. Ltd., F. Hoffmann-La Roche Ltd., Hologic Inc., Hologic Gen-Probe Incorporated, QIAGEN NV, and Seegene Inc.
The research report titled “HPV Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of major players worldwide. The report provides market estimates and projections in US$ for all major geographic markets such as the US, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), and Rest of World.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/HPV_Testing_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
###
